Early origins of adult disease: Low birth weight and vascular remodeling

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 391-399

  Visentin, Silvia ^a   Grumolato, Francesca ^a   Nardelli, Giovanni Battista ^a   Di Camillo, Barbara ^b   Grisan, Enrico ^b   Cosmi, Erich ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cardiovascular disease; Fetal programming; Intrauterine growth restriction; Long term consequences

Indexed keywords

ADOLESCENT DISEASE; ADULT DISEASE; ARTERIAL PRESSURE; ARTERIAL WALL THICKNESS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHILDHOOD DISEASE; CHILDHOOD OBESITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; EPIGENETICS; FETUS DISEASE; FOLLOW UP; HUMAN; INTRAUTERINE GROWTH RETARDATION; LIFESTYLE; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; MATERNAL OBESITY; NEWBORN DISEASE; NONHUMAN; PULSE WAVE; REVIEW; VASCULAR DISEASE; VASCULAR REMODELING;

EID: 84908389409     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.09.027     Document Type: Review

References (102)

1. Murphy S.L., Jiaquan Xu J., Kochanek K.D. Deaths: Preliminary Data for 2010. National Vital Statistics Report 2011, vol. 59. US Department of Health and Human Services, CDC, National Center for Health Statistics, Hyattsville, MD, 10.
2. Feener E.P., King G.L. Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail. Monit. 2001, 1:74-82.
3. Wilmot E., Edwardson C., Achana F., et al. Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia 2012, 55:2895-2905.
4. Atlanta G.A., Centers for Disease Control and Prevention Prevalence of Obesity Among U.S. Children and Adolescents (Aged 2-19 Years)-National Health and Nutrition Examination Surveys, NHANES (1976-1980 and 2003-2006) 2009.
5. Barker D.J. The developmental origins of well-being. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2004, 359:1359-1366.
6. Woolf B. Studies on infant mortality - part II. Social aetiology of stillbirths and infant deaths in county boroughs of England and Wales. J.Epidemiol. Community Health 1996, 50:613-619.
7. Barker D.J., Winter P.D., Osmond C., Margetts B., Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2:577-580.
8. Mellanby E. Nutrition and child-bearing. Lancet 1933, 222(5751):1131-1137.
9. Harding J.E. The nutritional basis of the fetal origins of adult disease. Int. J. Epidemiol. 2001, 30:15-23.
10. McMillen I.C., Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol. Rev. 2005, 85:571-633.
11. Lapillonne A. Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med. Hypotheses 2010, 74:71-75.
12. Lelievre-Pegorier M., Vilar J., Ferrier M.L., Moreau E., Freund N., Gilbert T., et al. Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int. 1998, 54:1455-1462.
13. Eriksson J.G., Forsen T.J., Osmond C., Barker D.J. Pathways of infant and childhood growth that lead to type 2 diabetes. Diabetes Care 2003, 26:3006-3010.
14. Keller G., Zimmer G., Mall G., Ritz E., Amann K. Nephron number in patients with primary hypertension. N.Engl. J. Med. 2003, 348:101-108.
15. Phillips D.I. Insulin resistance as a programmed response to fetal undernutrition. Diabetologia 1996, 39:1119-1122.
16. Barker D.J., Eriksson J.G., Forsen T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int. J. Epidemiol. 2002, 31:1235-1239.
17. Ozanne S.E., Dorling M.W., Wang C.L., Nave B.T. Impaired PI3-kinase activation in adipocytes from early growth restricted male rats. Am. J. Physiol. 2001, 280:E534-E539.
18. Nobili V., Marcellini M., Marchesini G., Vanni E., Manco M., Villani A., et al. Intrauterine growth retardation, insulin resistance, and non-alcoholic fatty liver disease in children. Diabetes Care 2007, 30:2638-2640.
19. Singhal A., Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis?. Lancet 2004, 363:1642-1645.
20. Minshall R.D., Malik A.B. Transport across the endothelium: regulation of endothelial permeability. Handb. Exp. Pharmacol. 2006, 176(Pt 1):107-144.
21. Minshall R.D., Tiruppathi C., Vogel S.M., Malik A.B. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem. Cell. Biol. 2002, 117:105-112.
22. Martin F.A., Murphy R.P., Cummins P.M. Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H1585-H1597.
23. Furchgott R.F., Zawadzki J.V. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
24. Flavahan N.A., Vanhoutte P.M. Endothelial cell signaling and endothelial dysfunction. Am. J. Hypertens. 1995, 8:28S-41S.
25. Chatterjee A., Black S.M., Catravas J.D. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc. Pharmacol. 2008, 49:134-140.
26. Mudau M., Genis A., Lochner A., Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc. J. Afr. 2012, 23:222-231.
27. Griendling K.K., FitzGerald G.A. Oxidative stress and cardiovascular injury. Part I. Basic mechanisms and invivo monitoring of ROS. Circulation 2003, 108:1912-1916.
28. Lockette W., Otsuka Y., Carretero O. The loss of endothelium dependent vascular relaxation in hypertension. Hypertension 1986, 8:II61-II66.
29. Resnick N., Yahav H., Shay-Salit A., Shushy M., Schubert S., et al. Fluid shear stress and the vascular endothelium: for better and for worse. Prog. Biophys. Mol. Biol. 2003, 81:177-199.
30. Movers and Shakers in the Vascular Tree-Hemodynamic and Biomechanical Factors in Blood Vessel Pathology Mar 11-12, 1999, in Bethesda.
31. Villar J., Belizan J.M. The timing factor in the pathophysiology of the intrauterine growth retardation syndrome. Obstet. Gynecol. Surv. 1982, 37:499-506.
32. Nuyt A.M. Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models. Clin. Sci. Lond. 2008, 114:1-17.
33. Jones C.T., Lafeber H.N., Roebuck M.M. Studies on the growth of the fetal guinea pig. Changes in plasma hormone concentration during normal and abnormal growth. J.Dev. Physiol. 1984, 6:461-472.
34. Bae S., Xiao Y., Li G., Casiano C.A., Zhang L. Effect of maternal chronic hypoxic exposure during gestation in apoptosis in fetal heart. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H983-H990.
35. Barker D.J.P., Bull A.R., Osmond O., Simmons S.J. Fetal and placental size and risk of hypertension in adult life. BMJ 1990, 301:259-262.
36. Langley-Evans S.C., Phillips G.J., Benediktsson R., Gardner D.S., Edwards C.R., Jackson A.A., Seckl J.R. Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta 1996, 173:169-172.
37. Luo Z.C., Fraser W.D., Julien P., Deal A.C., Audibert F., Smith G.N., et al. Tracing the origins of fetal origins of adult diseases: programming by oxidative stress. Med. Hypotheses 2006, 66:18-44.
38. Napoli C., Glass C.K., Witztum J.L., Deutsch R., D'Armiento F.P., Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999, 354:1234-1241.
39. Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995, 91:2488-2496.
40. Brenseke B., Prater M.R., Bahamonde J., Gutierrez C. Current thoughts on maternal nutrition and fetal programming of the metabolic syndrome. J.Pregnancy 2013.
41. Hattersley Andrew T., Tooke John E. The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 1999, 353:1789-1792.
42. Steinberg H.O., Brechtel G., Johnson A., Fineberg N., Baron A.D. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J.Clin. Invest. 1994, 94:1172-1179.
43. Burdge G.C., Hanson M.A., Slater-Jefferies J.L., Lillycrop K.A. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life?. Br. J. Nutr. 2007, 97(6):1036-1046.
44. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33(Suppl.l):245-254.
45. Lillycrop K.A., Phillips E.S., Jackson A.A., Hanson M.A., Burdge G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J.Nutr. 2005, 135:1382-1386.
46. Sinclair K., Allegrucci C., Singh R., Gardner D., Sebastian S., Bispham J. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19351-19356.
47. Krause B.J., Costello P.M., Muñoz-Urrutia E., Lillycrop K.A., Hanson M.A., Casanello P. Role of DNA methyltransferase 1 on the altered eNOS expression in human umbilical endothelium from intrauterine growth restricted fetuses. Epigenetics 2013 Sep, 8(9):944-952.
48. Gascoin-Lachambre G., Buffat C., Rebourcet R., Chelbi S.T., Rigourd V., Mondon F., Mignot T.M., Legras E., Simeoni U., Vaiman D., Barbaux S. Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. Placenta 2010, 31(2):151-157.
49. Anderson C.M., Lopez F., Zimmer A., Benoit J.N. Placental insufficiency leads to developmental hypertension and mesenteric artery dysfunction in two generations of Sprague-Dawley rat offspring. Biol. Reprod. 2006, 74:538-544.
50. Drake A.J., Walker B.R. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J.Endocrinol. 2004, 180:1-16.
51. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol. Rev. 2011, 91:827-887.
52. Oommen A.M., Griffin J.B., Sarath G., Zempleni J. Roles for nutrients in epigenetic events. J.Nutr. Biochem. 2005, 16:74-77.
53. McGill H.C., McMahan C.A., Herderick E.E., Malcom G.T., Tracy R.E., Strong J.P. Origin of atherosclerosis in childhood and adolescence. Am. J. Clin. Nutr. 2000, 72:1307S-1315S.
54. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
55. Skilton M.R., Evans N., Griffiths K.A., Harmer J.A., Celermajer D.S. Aortic wall thickness in newborns with intrauterine growth restriction. Lancet 2005, 365:1484-1486.
56. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J.Am. Coll. Cardiol. 2010, 55:1318-1327.
57. Aggoun Y., Szezepanski I., Bonnet D. Non invasive assessment of arterial stiffness and risk of atherosclerotic events in children. Pediatr. Res. 2005, 58:173-178.
58. Thayer J.F., Lane R.D. The role of vagal function in the risk for cardiovascular disease and mortality. Biol. Psychol. 2007, 74:224-242.
59. Martin Helena, Hu Jie, Gennser Gerhard, Norman Mikael Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation 2000, 102:2739-2744.
60. Witte D.R., Westerink J., de Koning E.J., van der Graaf Y., Grobbee D.E., Bots M.L. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?. J.Am. Coll. Cardiol. 2005, 45:1987-1993.
61. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 134: fetal growth restriction. Obstet. Gynecol. 2013, 121:1122-1133.
62. Unterscheider J., Daly S., Geary M.P., Kennelly M.M., et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am. J. Obstet. Gynecol. 2013, 208:290.e1-290.e6.
63. Gardosi J., Mongelli M., Wilcox M., et al. An adjustable fetal weight standard. Ultrasound Obstet. Gynecol. 1995, 6:168-174.
64. Royal College of Obstetricians and Gynecologists The Investigation and Management of the Small-for-gestational-age Fetus (Guideline No. 31) 2002, Royal College of Obstetricians and Gynecologists, London.
65. Society for Maternal-Fetal Medicine Publications Committee, Berkley E., Chauhan S.P., Abuhamad A. Doppler assessment of the fetus with intrauterine growth restriction. Am. J. Obstet. Gynecol. 2012, 206:300-308.
66. Baschat A.A., Cosmi E., Bilardo C.M., et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet. Gynecol. 2007, 109:253-261.
67. Rizzo G., Capponi A., Cavicchioni O., Vendola M., Arduini D. Low cardiac output to the placenta: an early hemodynamic adaptive mechanism in intrauterine growth restriction. Ultrasound Obstet. Gynecol. 2008, 32:155-159.
68. Al-Ghazali W., Chita S.K., Chapman M.G., Allan L.D. Evidence of redistribution of cardiac output in asymmetrical growth retardation. Br. J. Obstet. Gynaecol. 1989, 96:697-704.
69. Garg M., Thamotharan M., Dai Y., et al. Glucose intolerance and lipid metabolic adaptations in response to intrauterine and postnatal calorie restriction in male adult rats. Endocrinology 2013, 154:102-113.
70. White C.R., Haidekker M., Bao X., Frangos J.A. Temporal gradients in shear, but not spatial gradients, stimulate endothelial cell proliferation. Circulation 2001, 103:2508-2513.
71. Li G., Xiao Y., Estrella J.L., Ducsay C.A., Gilbert R.D., Zhang L. Effect of fetal hypoxia on heart susceptibility to ischemia and reperfusion injury in the adult rat. J.Soc. Gynecol. Investig. 2003, 10:265-274.
72. Brenner B.M., Garcia D.L., Anderson S. Glomeruli and blood pressure. Less of one, more the other?. Am. J. Hypertens. 1988, 1:335-347.
73. Baum M. Role of the kidney in the prenatal and early postnatal programming of hypertension. Am. J. Physiol. Renal Physiol. 2010, 298:F235-F247.
74. Mizuno M., Siddique K., Baum M., Smith S. Prenatal programming of hypertension induces sympathetic over activity in response to physical stress. Hypertension 2013 Jan, 61(1):180-186.
75. Cosmi E., Visentin S., Fanelli T., Mautone A.J., Zanardo V. Aortic intima media thickness in fetuses and children with intrauterine growth restriction. Obstet. Gynecol. 2009, 114:1109-1114.
76. Jarvisalo M.J., Jartti L., Nanto-Salonen K., et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001, 104:2943-2947.
77. Comas M., Crispi F., Cruz-Martinez R., Figueras F., Gratacos E. Tissue Doppler echocardiographic markers of cardiac dysfunction in small-for-gestational age fetuses. Am. J. Obstet. Gynecol. 2011, 205:57.e1-57.e6.
78. Ley D., Stale H., Marsal K. Aortic vessel wall characteristics and blood pressure in children with intrauterine growth retardation and abnormal fetal aortic blood flow. Acta Paediatr. 1997, 86:299-305.
79. Norman Mikael, Martin Helena Preterm birth attenuates association between low birth weight and endothelial dysfunction. Circulation 2003, 108:996-1001.
80. Leeson C.P., Whincup P.H., Cook D.G., et al. Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation 1997, 96:2233-2238.
81. Nilsson P.M., Ostergren P.O., Nyberg P., Söderström M., Allebeck P. Low birth weight is associated with elevated systolic blood pressure in adolescence: a prospective study of a birth cohort of 149,378 Swedish boys. J.Hypertens. 1997, 15:1627-1631.
82. Koklu E., Kurtoglu S., Akcakus M., et al. Increased aortic intima-media thickness is related to lipid profile in newborns with intrauterine growth restriction. Horm. Res. 2006, 65:269-275.
83. Meyer W.W., Lind J., Yao A.C., Kauffman S.L. Early arterial lesions in infancy and childhood and ways of prevention. Paediatrician 1982, 11:136-156.
84. Lo Vasco V.R., Salmaso R., Zanardo V., et al. Fetal aorta wall inflammation in ultrasound detected aortic intima/media thickness and growth retardation. J.Reprod. Immunol. 2011, 91:103-107.
85. Visentin S., Grisan E., Zanardo V., et al. Developmental programming of cardiovascular risk in intrauterine growth-restricted twin fetuses according to aortic intima thickness. J.Ultrasound Med. 2013, 32:279-284.
86. Cecconi D., Lonardoni F., Favretto D., et al. Changes in amniotic fluid and umbilical cord serum proteomic profiles of fetuses with intrauterine growth retardation. Electrophoresis 2011, 32:3630-3637.
87. Favretto D., Cosmi E., Ragazzi E., et al. Cord blood metabolomic profiling in intrauterine growth restriction. Anal. Bioanal. Chem. 2012, 402:1109-1121.
88. Cosmi E., Visentin S., Favretto D., Tucci M., Ragazzi E., Viel G., Ferrara S.D. Selective intrauterine growth restriction in monochorionic twin pregnancies: markers of endothelial damage and metabolomic profile. Twin Res. Hum. Genet. 2013 Aug, 16(4):816-826.
89. Spijkers L.J., van den Akker R.F., Janssen B.J., et al. Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide. PLoS One 2011, 6:e21817.
90. Brenner B.M., Lawler E.V., Mackenzie H.S. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996, 49:1774-1777.
91. Zanardo V., Fanelli T., Weiner G., et al. Intrauterine growth restriction is associated with persistent aortic wall thickening and glomerular proteinuria during infancy. Kidney Int. 2011, 80:119-123.
92. Rich-Edwards J.W., Kleinman K., Michels K.B., et al. Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women. BMJ 2005, 330:1115.
93. Liao D., Arnett D.K., Tyroler H.A., et al. Arterial stiffness and the development of hypertension: the ARIC study. Hypertension 1999, 34:201-206.
94. Huxley R., Neil A., Collins R. Unravelling the fetal origins hypothesis: is there really an inverse association between birth weight and subsequent blood pressure?. Lancet 2002, 360:659-665.
95. Leunissen R.W.J., Kerkhof G.F., Stijnen T., Hokken-Koelega A.C.S. Effect of birth size and catch-up growth on adult blood pressure and carotid intima-media thickness. Horm. Res. Paediatr. 2012, 77:394-401.
96. Uiterwaal C.S., Anthony S., Launer L.J., Witteman J.C., Trouwborst A.M., Hofman A., Grobbee D.E. Birth weight, growth, and blood pressure: an annual follow-up study of children aged 5 through 21 years. Hypertension 1997, 30:267-271.
97. Adair L.S., Cole T.J. Rapid child growth raises blood pressure in adolescent boys who were thin at birth. Hypertension 2003, 41:451-456.
98. Oren A., Vos L.E., Uiterwaal C.S., Gorissen W.H., Grobbee D.E., Bots M.L. Birth weight and carotid intima-media thickness: new perspectives from the atherosclerosis risk in young adults (ARYA) study. Ann. Epidemiol. 2004, 14:8-16.
99. Santos M.S., Joles J.A. Early determinants of cardiovascular disease. Best. Pract. Res. Clin. Endocrinol. Metab. 2012, 26:581-597.
100. Skilton M.R., Mikkila V., Wurtz P., Ala-Korpela M., Sim K.A., Soininen P., Kangas A.J., Viikari J.S., Juonala M., Laitinen T., Lehtimaki T., Taittonen L., Kahonen M., Celermajer D.S., Raitakari O.T. Fetal growth, omega-3 (ω-3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The Cardiovascular Risk in Young Finns Study. Am. J. Clin. Nutr. 2013, 97:58-65.
101. Williams C.L., Hayman L.L., Daniels S.R., Robinson T.N., Steinberger J., Paridon S., Bazzarre T. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002, 106:143-160.
102. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren W.M., Albus C., Benlian P., Boysen G., Cifkova R., Deaton C., Ebrahim S., Fisher M., Germano G., Hobbs R., Hoes A., Karadeniz S., Mezzani A., Prescott E., Ryden L., Scherer M., Syvanne M., et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2012, 33:1635-1701.